Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Can amyloidosis regress?]

J M Dray1, O Blétry

  • 1Service de médecine interne, Hôpital Foch, Suresnes.

La Revue Du Praticien
|February 7, 1998
PubMed
Summary

Amyloidosis treatment varies by type, with some forms showing improvement after addressing underlying causes or specific therapies. While complete recovery is rare, treatments can stabilize or slightly improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Spontaneous streptococcal arthritis of the pubic symphysis].

La Revue de medecine interne·2010
Same author

[Painful legs in a 45-year-old man].

La Revue de medecine interne·2010
Same author

[Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].

La Revue de medecine interne·2010
Same author

[What's new in internal medicine?].

Annales de dermatologie et de venereologie·2010
Same author

Hemophagocytic syndrome in the course of Crohn's disease: possible association with cytomegalovirus infection.

The American journal of gastroenterology·2008
Same author

[Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease].

La Revue de medecine interne·2007

Area of Science:

  • Internal Medicine
  • Genetics
  • Nephrology

Context:

  • Amyloidosis encompasses a group of progressive diseases characterized by extracellular deposition of misfolded proteins.
  • Prognosis and treatment efficacy are highly dependent on the specific type of amyloidosis.
  • Untreated amyloidosis invariably leads to disease progression.

Purpose:

  • To review the treatment strategies and outcomes for different types of amyloidosis.
  • To highlight the variable response to therapies based on amyloidosis subtype.
  • To discuss the potential for disease stabilization or improvement with current treatment modalities.

Summary:

  • AA amyloidosis may improve with treatment of the underlying condition or colchicine therapy for familial Mediterranean fever, though histological regression is uncommon.
  • Familial amyloidosis with transthyretin mutation can show slight clinical improvement or stabilization post-liver transplantation, despite high mortality and short follow-up.
  • AL amyloidosis has a poor prognosis (median survival <15 months), but chemotherapy regimens used for multiple myeloma may improve survival or stabilize the disease.

Impact:

  • Treatment strategies need to be tailored to the specific type of amyloidosis for optimal patient outcomes.
  • Further research is needed to improve long-term survival and histological regression in amyloidosis.
  • Understanding treatment responses can guide clinical management and patient counseling.

Related Experiment Videos